Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Development of uncoated near-spherical gold nanoparticles for the label-free quantification of Lactobacillus rhamnosus GG by surface-enhanced Raman spectroscopy.

Akanny E, Bonhommé A, Commun C, Doleans-Jordheim A, Bessueille F, Bourgeois S, Bordes C.

Anal Bioanal Chem. 2019 Jun 17. doi: 10.1007/s00216-019-01938-4. [Epub ahead of print]

PMID:
31209547
2.

In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract.

Dumont C, Bourgeois S, Fessi H, Dugas PY, Jannin V.

Int J Pharm. 2019 Jun 30;565:409-418. doi: 10.1016/j.ijpharm.2019.05.037. Epub 2019 May 14.

PMID:
31100381
3.

Behaviour of Tetrabenazine in Acid Medium: Reassessment and Impact on Formulation.

Ettouati L, Senta-Loys Z, Bourgeois S, Fenet B, Borgne ML, Fessi H.

Pharmaceutics. 2019 Jan 20;11(1). pii: E44. doi: 10.3390/pharmaceutics11010044.

4.

Lipid-based nanosuspensions for oral delivery of peptides, a critical review.

Dumont C, Bourgeois S, Fessi H, Jannin V.

Int J Pharm. 2018 Apr 25;541(1-2):117-135. doi: 10.1016/j.ijpharm.2018.02.038. Epub 2018 Feb 21. Review.

PMID:
29476783
5.

Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.

Dubald M, Bourgeois S, Andrieu V, Fessi H.

Pharmaceutics. 2018 Jan 13;10(1). pii: E10. doi: 10.3390/pharmaceutics10010010. Review.

6.

Orodispersible films based on amorphous solid dispersions of tetrabenazine.

Senta-Loys Z, Bourgeois S, Valour JP, Briançon S, Fessi H.

Int J Pharm. 2017 Feb 25;518(1-2):242-252. doi: 10.1016/j.ijpharm.2016.12.036. Epub 2016 Dec 19.

PMID:
28007543
7.

Problems associated with the microbiological control of the breast milk from hospital milk bank units.

Lecointe D, Assoukpa J, Cezard L, Descaves C, Gouot A, Bourgeois S, Bergeon M, Koutcherenko S, Lakhdari Y, Kassidi N.

Ann Biol Clin (Paris). 2016 Dec 1;74(6):747-756.

PMID:
27777185
8.

Formulation of orodispersible films for paediatric therapy: investigation of feasibility and stability for tetrabenazine as drug model.

Senta-Loys Z, Bourgeois S, Pailler-Mattei C, Agusti G, Briançon S, Fessi H.

J Pharm Pharmacol. 2017 May;69(5):582-592. doi: 10.1111/jphp.12627. Epub 2016 Sep 27.

PMID:
27671542
9.

Pectin gelation with chlorhexidine: Physico-chemical studies in dilute solutions.

Lascol M, Bourgeois S, Guillière F, Hangouët M, Raffin G, Marote P, Lantéri P, Bordes C.

Carbohydr Polym. 2016 Oct 5;150:159-65. doi: 10.1016/j.carbpol.2016.05.014. Epub 2016 May 9.

PMID:
27312625
10.

Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment.

Lee MY, Bourgeois S, Almouazen E, Pelletier J, Renaud F, Fessi H, Kodjikian L.

Int J Pharm. 2016 May 30;505(1-2):262-70. doi: 10.1016/j.ijpharm.2016.03.026. Epub 2016 Mar 17.

PMID:
26997423
11.

[Accreditation of a hygiene hospital laboratory for sampling and analysis activities for the detection and counting of Legionella in water].

Lecointe D, Noël C, Beauvais R, Descaves C, Gouot A, Bourgeois S, Koutcherenko S, Kassidi N.

Ann Biol Clin (Paris). 2015 May-Jun;73(3):369-79. doi: 10.1684/abc.2015.1041. French.

12.

The development, physicochemical characterisation and in vitro drug release studies of pectinate gel beads containing Thai mango seed kernel extract.

Nithitanakool S, Pithayanukul P, Bourgeois S, Fessi H, Bavovada R.

Molecules. 2013 Jun 3;18(6):6504-20. doi: 10.3390/molecules18066504.

13.

Nano-encapsulation of vitamin D3 active metabolites for application in chemotherapy: formulation study and in vitro evaluation.

Almouazen E, Bourgeois S, Jordheim LP, Fessi H, Briançon S.

Pharm Res. 2013 Apr;30(4):1137-46. doi: 10.1007/s11095-012-0949-4. Epub 2012 Dec 8.

PMID:
23225028
14.

A safe and practical method for the preparation of 7α-thioether and thioester derivatives of spironolactone.

Agusti G, Bourgeois S, Cartiser N, Fessi H, Le Borgne M, Lomberget T.

Steroids. 2013 Jan;78(1):102-7. doi: 10.1016/j.steroids.2012.09.005. Epub 2012 Oct 10.

PMID:
23063964
15.

Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages.

Almouazen E, Bourgeois S, Boussaïd A, Valot P, Malleval C, Fessi H, Nataf S, Briançon S.

Int J Pharm. 2012 Jul 1;430(1-2):207-15. doi: 10.1016/j.ijpharm.2012.03.025. Epub 2012 Mar 21.

PMID:
22465633
16.

Development of an original method to study drug release from polymeric nanocapsules in the skin.

Weiss-Angeli V, Bourgeois S, Pelletier J, Guterres SS, Fessi H, Bolzinger MA.

J Pharm Pharmacol. 2010 Jan;62(1):35-45. doi: 10.1211/jpp.62.01.0003.

PMID:
20722997
17.

Cerebral monoamine oxidase A inhibition in tobacco smokers confirmed with PET and [11C]befloxatone.

Leroy C, Bragulat V, Berlin I, Grégoire MC, Bottlaender M, Roumenov D, Dollé F, Bourgeois S, Penttilä J, Artiges E, Martinot JL, Trichard C.

J Clin Psychopharmacol. 2009 Feb;29(1):86-8. doi: 10.1097/JCP.0b013e31819e98f.

PMID:
19142115
18.

Development of a novel nanocapsule formulation by emulsion-diffusion combined with high hydrostatic pressure.

Lee MY, Min SG, Bourgeois S, Choi MJ.

J Microencapsul. 2009 Mar;26(2):122-9. doi: 10.1080/02652040802193006 .

PMID:
18608795
19.

Colonic delivery of beta-lactamases does not affect amoxicillin pharmacokinetics in rats.

Bourgeois S, Tsapis N, Honnas H, Andremont A, Shakweh M, Besnard M, Fattal E.

J Pharm Sci. 2008 May;97(5):1853-63.

PMID:
17803197
20.

The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.

Ribeiro MJ, Boddaert N, Bellanné-Chantelot C, Bourgeois S, Valayannopoulos V, Delzescaux T, Jaubert F, Nihoul-Fékété C, Brunelle F, De Lonlay P.

Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2120-8. Epub 2007 Jul 28.

PMID:
17661030

Supplemental Content

Loading ...
Support Center